NSEBSECOMMODITYNASDAQNYSEFOREXINDICESAMEXUSA .

Famous Munafa Ebook, free scanners! Intraday scanner, FNO scanner, High profit BTST stocks!

Aurinia Pharmaceuticals (AUPH) Technical (Analysis) Reports Aurinia Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Aurinia Pharmaceuticals (AUPH)

Technical Analysis Report for NASDAQ stock AUPH Aurinia Pharmaceuticals. Dated: 22 May 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock AUPH Aurinia Pharmaceuticals then click here. or read Experts views on Aurinia Pharmaceuticals or Forecast & share price targets of Aurinia Pharmaceuticals

Aurinia Pharmaceuticals Opened at 15.60 and Closed at: 15.22, which is -1.51% of previous session's close. It moved within a range of 15.06 and 15.60
The session was a Bearish session with an average volume of 994100, which is 7.46% of previous session's volumes.

• The stock has fallen, and its short term trend is also negative and in a downtrend.
• Even though the stock has fallen, but its mid term trend is positive and in an uptrend.
• Even though the stock has fallen, but its long term trend is positive and in an uptrend.

Support for tomorrow is 14.87 and resistance for tomorrow is 15.41
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 14.99, 14.75 resistance for tomorrow's hourly charts is 15.53, 15.83

10 Day SMA for Aurinia Pharmaceuticals (AUPH) is 15.66 and stock is trading below these levels. This is not a good sign for its short term trend

20 Day SMA for Aurinia Pharmaceuticals (AUPH) is 15.67 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Aurinia Pharmaceuticals (AUPH) is 15.44 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 15.08 and the stock is trading above these levels. This is a good sign for its long term trend

200 Day SMA Aurinia Pharmaceuticals is 14.27 and stock is trading above these levels. This is a good sign for its long term trend

20 DMA of Aurinia Pharmaceuticals is at 15.67 and 200 DMA is at 14.27, while 50 DMA and 100 DMA are at 15.44 and 15.08 respectively

Aurinia Pharmaceuticals (AUPH) moving average of 20 SMA is at 15.67 and 20 EMA is at 15.65

Aurinia Pharmaceuticals (AUPH) moving average of 50 SMA is at 15.44 and 50 EMA is at 15.48

Aurinia Pharmaceuticals (AUPH) moving average of 100 SMA is at 15.08 and 100 EMA is at 15.07

Aurinia Pharmaceuticals (AUPH) moving average of 200 SMA is at 14.27 and 200 EMA is at 13.98

Aurinia Pharmaceuticals has performed better than 111 Inc in short term. Holding Aurinia Pharmaceuticals could be a better choice for now!

Tactile Systems has performed better than Aurinia Pharmaceuticals in short term. You could have earned much better returns by investing in Tactile Systems, about 10.75% more returns!

Riot Blockchain has performed better than Aurinia Pharmaceuticals in short term. You could have earned much better returns by investing in Riot Blockchain, about 52.85% more returns!

Aurinia Pharmaceuticals has performed better than Regeneron Pharmaceuticals in short term. Holding Aurinia Pharmaceuticals could be a better choice for now!

Oramed Pharmaceuticals has performed better than Aurinia Pharmaceuticals in short term. You could have earned much better returns by investing in Oramed Pharmaceuticals, about 4.12% more returns!

Aurinia Pharmaceuticals has performed better than Omeros Corporation in short term. Holding Aurinia Pharmaceuticals could be a better choice for now!

Aurinia Pharmaceuticals has performed better than Kodiak Sciences in short term. Holding Aurinia Pharmaceuticals could be a better choice for now!

Kala Pharmaceuticals has performed better than Aurinia Pharmaceuticals in short term. You could have earned much better returns by investing in Kala Pharmaceuticals, about 2114.2% more returns!

Aurinia Pharmaceuticals has performed better than Adma Biologics in short term. Holding Aurinia Pharmaceuticals could be a better choice for now!

Assertio Therapeutics has performed better than Aurinia Pharmaceuticals in short term. You could have earned much better returns by investing in Assertio Therapeutics, about 35.04% more returns!

Biogen Inc has performed better than Aurinia Pharmaceuticals in short term. You could have earned much better returns by investing in Biogen Inc, about 10.77% more returns!

Catalyst Pharmaceuticals has performed better than Aurinia Pharmaceuticals in short term. You could have earned much better returns by investing in Catalyst Pharmaceuticals, about 11.29% more returns!

Fennec Pharmaceuticals has performed better than Aurinia Pharmaceuticals in short term. You could have earned much better returns by investing in Fennec Pharmaceuticals, about 53.32% more returns!

Guardant Health has performed better than Aurinia Pharmaceuticals in short term. You could have earned much better returns by investing in Guardant Health, about 48.27% more returns!

Aurinia Pharmaceuticals has performed better than Gossamer Bio in short term. Holding Aurinia Pharmaceuticals could be a better choice for now!

Aurinia Pharmaceuticals has performed better than Insmed Inc in short term. Holding Aurinia Pharmaceuticals could be a better choice for now!

Aurinia Pharmaceuticals Technical analysis of indicators

Price action analysis of Aurinia Pharmaceuticals (AUPH) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.

ADX buy sell signal for Aurinia Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.

MACD generated a SELL signal for Aurinia Pharmaceuticals in short term but the sell signal is initial and weak.

Aurinia Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.

Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down

CCI has generated a SELL signal for Aurinia Pharmaceuticals in short term and SELL signal is strong!

RSI is generating a SELL signal in short term but selling is losing momentum.

MRSI is in negative zone. This is the SELL zone

Stock of Aurinia Pharmaceuticals is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 15.7 and Aurinia Pharmaceuticals AUPH stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.

People seem to be coming out and selling the Aurinia Pharmaceuticals AUPH stock. Volume based technical analysis of Aurinia Pharmaceuticals AUPH stock is negative.

Aurinia Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NASDAQ stock AUPH Aurinia Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And AUPH Experts View which covers a lot of information including buying and selling signals

AUPH future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Aurinia Pharmaceuticals or View Candle Stick Charts here

Share on: WhatsApp Facebook Tweet